Trial Profile
A comparison of Symbicort single inhaler therapy (Symbicort Turbohaler [Turbuhaler] 160/4.5 mg, 1 inhalation b.i.d. plus as needed) and conventional best practice for the treatment of persistent asthma in adolescents and adults - a 26-week, randomised, open-label, parallel-group, multi-centre study (SALTO).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jun 2013
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms SALTO
- Sponsors AstraZeneca
- 01 Oct 2009 Results published in the International Journal of Clinical Practice.
- 29 Mar 2006 New trial record.